Hypertrophic cardiomyopathy (HCM) is often associated with reduced exercise capacity, and structured exercise has traditionally been limited because of concerns about arrhythmias and sudden cardiac death. Although emerging evidence suggests that supervised, individualized exercise may be safe in selected patients, data on hybrid cardiac telerehabilitation (HCT) in non-obstructive HCM remain limited. To address this gap, a study evaluated the efficacy and safety of a 12-week HCT program in 60 patients with non-obstructive HCM and preserved left ventricular ejection fraction.
The study found that hybrid cardiac telerehabilitation (HCT) resulted in a significantly greater improvement in peak oxygen uptake (pVO₂) compared with usual care (between-group difference: +1.35 ml/kg/min). Significant improvements were also observed in 6-minute walk test distance, and perceived health status…
